ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryIndustryMedical Technology IndustryZurichSANTERSUS AG
SANTERSUS AG Logo
Verified· 2 sources

SANTERSUS AG

Summary

About the company

The core activity of Santersus AG is the development and application of Therapeutic Apheresis technologies, particularly for the treatment of diseases such as sepsis, cancer, autoimmune diseases, COVID-19 and transplantation. The company focuses on the development of devices and applications for blood purification and treatment.

AI-generated
Offering

Products & services

Industry:Medical Technology Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered5
Therapeutic Apheresis with NucleoCapture
Therapeutic apheresis for the selective extracorporeal removal of neutrophil extracellular traps (NETs) from blood, integrable into existing plasmapheresis and sepsis treatment protocols.
NucleoCapture apheresis device
Selective apheresis device for the removal of circulating NETs and other cell-free DNA fragments from blood; developed as a blood purification technology for therapeutic applications.
Treatments for sepsis and autoimmune diseases
NET-targeted therapies for sepsis, lupus (SLE) and other autoimmune diseases; clinical development with reference to critical care and first feasibility data.
Therapies for transplant indications
NET-targeted therapies for lung transplantation and liver transplantation in the clinical pipeline program, as additional follow-on indications of the apheresis technology.
Diagnostic cell-free DNA extraction
In vitro diagnostic (IVD) microdevice for extraction of cell-free DNA for liquid biopsy and non-invasive prenatal tests; based on NucleoCapture technology.

Knowledge

No knowledge articles yet

Once SANTERSUS AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

SANTERSUS AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank SANTERSUS AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of SANTERSUS AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Nüschelerstrasse 45
8001 Zurich

At a glance

Legal form
Corporation
UID
CHE-210.366.165
Founded
2017 · 9 years
Last commercial register change
July 8, 2026
Employees
1 to 10

Similar companies

NA
noson AG
Zurich
RO
Rombach Orthopädie-Schuhtechnik AG
Schlieren
OA
Orthoschritt.ch AG
Zurich
AG
AtropaSwiss GmbH
Dietlikon